Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: An application in Huntington disease

BioMedical Engineering Online

Volumn 13, Issue 1, 2014, Pages

  Müller, Hans Peter ^a   Kassubek, Jan ^a   Grön, Georg ^a   Sprengelmeyer, Reiner ^b   Ludolph, Albert C ^a   Klöppel, Stefan ^c   Hobbs, Nicola Z ^d   Roos, Raymund A C ^e   Duerr, Alexandra ^f   Tabrizi, Sarah J ^d   Orth, Michael ^a   Süssmuth, Sigurd D ^a   Landwehrmeyer, G B ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Corrupted raw data; Diffusion tensor imaging; Fractional anisotropy; Huntington disease; Multicenter study

Indexed keywords

CORRUPTED RAW DATA; DIFFUSION TENSOR; FRACTIONAL ANISOTROPY; GROUP LEVEL; HUNTINGTON DISEASE; MULTICENTER STUDY;

DIFFUSION TENSOR IMAGING;

ALGORITHM; ANALYTICAL ERROR; ANALYTICAL PARAMETERS; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRUPTED GRADIENT DIRECTION; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; DIFFUSION TENSOR IMAGING; DISEASE COURSE; FOLLOW UP; FRACTIONAL ANISOTROPY; HUMAN; HUNTINGTON CHOREA; INFORMATION PROCESSING; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE SCANNER; QUALITY CONTROL; RISK REDUCTION; SIGNAL NOISE RATIO; ANISOTROPY; BRAIN; CASE CONTROL STUDY; HUNTINGTON DISEASE; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; THEORETICAL MODEL; ULTRASTRUCTURE;

ALGORITHMS; ANISOTROPY; BRAIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIFFUSION TENSOR IMAGING; HUMANS; HUNTINGTON DISEASE; MODELS, THEORETICAL; REPRODUCIBILITY OF RESULTS;

EID: 84910067151     PISSN: None     EISSN: 1475925X     Source Type: Journal    
DOI: 10.1186/1475-925X-13-128     Document Type: Article

References (24)

1. Bach D, Behrens T, Garrido L, Weiskopf N, Dolan R. Deep and superficial amygdala nuclei projections revealed in vivo by probabilistic tractography. J Neurosci 2011, 31:618-623. 10.1523/JNEUROSCI.2744-10.2011, 3059574, 21228170.
2. Farzinfar M, Oguz I, Smith RG, Verde AR, Dietrich C, Gupta A, Escolar ML, Piven J, Pujol S, Vachet C, Gouttard S, Gerig G, Dager S, McKinstry RC, Paterson S, Styner MA, Evans AC, . IBIS network Diffusion imaging quality control via entropy of principal direction distribution. Neuroimage 2013, 82:1-12. IBIS network.
3. Mukherjee P, Chung S, Berman J, Hess C, Henry R. Diffusion tensor MR imaging and fiber tractography: technical considerations. Am J Neuroradiol 2008, 29:843-852. 10.3174/ajnr.A1052, 18339719.
4. Liu Z, Wang Y, Gerig G, Gouttard S, Tao R, Fletcher T, Styner M. Quality control of diffusion weighted images. Proc of SPIE 2010, 7628(76200J):1-9.
5. Hasan KM. A framework for quality control and parameter optimization in diffusion tensor imaging: theoretical analysis and validation. Magn Reson Imaging 2007, 25:1196-1202. 10.1016/j.mri.2007.02.011, 2185542, 17442523.
6. Müller H-P, Süssmuth SD, Landwehrmeyer GB, Ludolph AC, Tabrizi SJ, Klöppel S, Kassubek J. Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington's disease. PLoS Curr 2011, 3:RRN1292. 3269342,3269342, 22307262.
7. Lauzon CB, Asman AJ, Esparza ML, Burns SS, Fan Q, Gao Y, Anderson AW, Davis N, Cutting LE, Landman BA. Simultaneous analysis and quality assurance for diffusion tensor imaging. PLoS One 2013, 8:e61737. 10.1371/journal.pone.0061737, 3640065, 23637895.
8. Bohanna I, Georgiou-Karistianis N, Hannan AJ, Egan GF. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res Rev 2008, 58:209-225. 10.1016/j.brainresrev.2008.04.001, 18486229.
9. Klöppel S, Henley SM, Hobbs NZ, Wolf RC, Kassubek J, Tabrizi SJ, Frackowiak RS. Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience 2009, 164:205-219. 10.1016/j.neuroscience.2009.01.045, 2771270, 19409230.
10. Rosas HD, Tuch DS, Hevelone ND, Zaleta AK, Vangel M, Hersch SM, Salat DH. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Mov Disord 2006, 21:1317-1325. 10.1002/mds.20979, 16755582.
11. Douaud G, Behrens TE, Poupon C, Cointepas Y, Jbabdi S, Gaura V, Golestani N, Krystkowiak P, Verny C, Damier P, Bachoud-Lévi AC, Hantraye P, Remy P. In vivo evidence for the selective subcortical degeneration in Huntington's disease. Neuroimage 2009, 46:958-966. 10.1016/j.neuroimage.2009.03.044, 19332141.
12. Müller H-P, Grön G, Sprengelmeyer R, Kassubek J, Ludolph AC, Hobbs N, Cole J, Roos RAC, Duerr A, Tabrizi SJ, Landwehrmeyer GB, Süssmuth SD. Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach. Neuroimage Clin 2013, 2:161-167. 3777841, 24179771.
13. Hobbs NZ, Cole JH, Farmer RE, Rees EM, Crawford HE, Malone IB, Roos RA, Sprengelmeyer R, Durr A, Landwehrmeyer B, Scahill RI, Tabrizi SJ, Frost C. Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study. Neuroimage Clin 2013, 2:204-211.
14. Le Bihan D, van Zijl P. From the diffusion coefficient to the diffusion tensor. NMR Biomed 2002, 15:431-434. 10.1002/nbm.798, 12489093.
15. Basser PJ, Jones DK. Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed 2002, 15:456-467. 10.1002/nbm.783, 12489095.
16. DiPietroPaolo D, Müller H-P, Erné SN. A Novel Approach for the Averaging of Magnetocardiographic Recorded Heart Beats. Phys Med Biol 2005, 50:2415-2426. 10.1088/0031-9155/50/10/016, 15876676.
17. Ni H, Kavcic V, Zhu T, Ekholm S, Zhong J. Effects of number of diffusion gradient directions on derived diffusion tensor imaging indices in human brain. AJNR Am J Neuroradiol 2006, 27:1776-1781.
18. Farrell JA, Landman BA, Jones CK, Smith SA, Prince JL, van Zijl PC, Mori S. Effects of signal-to-noise ratio on the accuracy and reproducibility of diffusion tensor imaging-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5 T. J Magn Reson Imaging 2007, 26:756-767. 10.1002/jmri.21053, 2862967, 17729339.
19. Müller H-P, Unrath A, Ludolph AC, Kassubek J. Preservation of diffusion tensor properties during spatial normalization by use of tensor imaging and fibre tracking on a normal brain database. Phys Med Biol 2007, 52:N99-N109. 10.1088/0031-9155/52/6/N01, 17327646.
20. Müller H-P, Kassubek J. Diffusion tensor magnetic resonance imaging in the analysis of neurodegenerative diseases. J Vis Exp 2013, 77:e50427.
21. Brett M, Johnsrude IS, Owen AM. The problem of functional localization in the human brain. Nat Rev Neurosci 2002, 3:243-249. 10.1038/nrn756, 11994756.
22. Unrath A, Müller HP, Riecker A, Ludolph AC, Sperfeld AD, Kassubek J. Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging. Hum Brain Mapp 2010, 31:1727-1740.
23. Kunimatsu A, Aoki S, Masutani Y, Abe O, Hayashi N, Mori H, Masumoto T, Ohtomo K. The optimal trackability threshold of fractional anisotropy for diffusion tensor tractography of the corticospinal tract. Magn Reson Med Sci 2004, 3:11-17. 10.2463/mrms.3.11, 16093615.
24. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002, 15:870-878. 10.1006/nimg.2001.1037, 11906227.